A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+5.42%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
Cap. Flow
-$4.44M
Cap. Flow %
-3.22%
Top 10 Hldgs %
92.68%
Holding
18
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

1
CBAY
Cymabay Therapeutics
CBAY
$3.64M
2
CRSP icon
CRISPR Therapeutics
CRSP
$482K
3
INNL
Innocoll Holdings plc Ordinary Shares
INNL
$322K

Sector Composition

1 Healthcare 97.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$45.8M 33.18% 1,951,359 -20,548 -1% -$482K
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$30.9M 22.35% 2,199,012 – –
PRTK
3
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$18.6M 13.5% 1,041,131 – –
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$10.6M 7.65% 1,147,077 -395,645 -26% -$3.64M
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$4.29M 3.11% 440,000 – –
ONCT
6
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$4.28M 3.1% 339,174 – –
TARA icon
7
Protara Therapeutics
TARA
$120M
$3.73M 2.7% 2,017,872 – –
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.43M 2.49% 2,080,595 – –
CASC
9
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.42M 2.48% 925,000 – –
CLLS
10
Cellectis
CLLS
$258M
$2.92M 2.11% 100,000 – –
DERM
11
DELISTED
Dermira, Inc.
DERM
$1.95M 1.41% 70,000 – –
OCGN icon
12
Ocugen
OCGN
$319M
$1.8M 1.31% 888,889 – –
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.89B
$1.77M 1.28% 38,100 – –
ADAP
14
Adaptimmune Therapeutics
ADAP
$15.6M
$1.67M 1.21% 250,000 – –
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
$1.37M 1% 352,300 – –
AUPH icon
16
Aurinia Pharmaceuticals
AUPH
$1.58B
$1.14M 0.83% 252,129 – –
EVAR
17
DELISTED
Lombard Medical, Inc.
EVAR
$399K 0.29% 3,473,452 – –
INNL
18
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
– – -537,235 Closed -$322K